Location: Plainsboro, New Jersey, USA.
Based on news reporting.
Novo Nordisk, the manufacturer of the weight loss drug Wegovy, is facing potential layoffs due to slowing sales. Although specific numbers of affected employees have not been disclosed, the company is reportedly considering job cuts as part of its response to the declining demand for its products. The situation reflects broader challenges in the pharmaceutical industry, particularly in the weight loss sector. As the company navigates these difficulties, it has not yet finalized any plans regarding the layoffs, leaving uncertainty for its workforce.
Novo Nordisk cut 3,000 jobs.
That is roughly 6.7% of the 45,000 people Novo Nordisk employs.
LayoffTalk has tracked 37 layoff events at Novo Nordisk since October 2023, affecting a combined 43,047 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
Novo Nordisk has announced planned job cuts affecting 3,000 employees. If you work there, what are you hearing internally? Which teams expect to be affected? You can post anonymously below.
Estimated figure based on news reporting. Not yet confirmed by Novo Nordisk.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.